Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa

Schnippel K.; Firnhaber C.; Berhanu R.; Page-Shipp L.; Sinanovic E.

首页> 外文期刊>The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease >Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa

【24h】

Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa

机译：在南非利福平抗性结核治疗期间管理不良药物反应的直接成本

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE: To estimate the provider costs of managing adverse drug reactions (ADRs) to standard long-course treatment for multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) according to South African guidelines.

机译：目的：估算管理不良药物反应（ADR）对南非指导方针的多药和利福平抗性结核（MDR / RR-TB）的标准长期治疗的提供者成本。

著录项

来源
《The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease》 |2018年第4期|共14页
作者
Schnippel K.; Firnhaber C.; Berhanu R.; Page-Shipp L.; Sinanovic E.;
展开▼
作者单位

Univ Cape Town Fac Hlth Sci Sch Family &

Publ Hlth Hlth Econ Unit Cape Town South Africa;

Univ Witwatersrand Fac Hlth Sci Dept Internal Med Clin HIV Res Unit Johannesburg South Africa;

Univ N Carolina Sch Med Div Infect Dis Chapel Hill NC USA;

Interact Res &

Dev Johannesburg South Africa;

Univ Cape Town Fac Hlth Sci Sch Family &

Publ Hlth Hlth Econ Unit Cape Town South Africa;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
multidrug-resistant tuberculosis; Markov model; budget impact; adverse events;

机译：多药抗性结核;马尔可夫模型;预算影响;不良事件;

相似文献

外文文献
中文文献
专利

1. Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa [J] . Schnippel K., Firnhaber C., Berhanu R., The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease . 2018,第4期

机译：在南非利福平抗性结核治疗期间管理不良药物反应的直接成本
2. Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases [J] . Jackie Jones, Vanessa Mudaly, Jacqueline Voget, BMC Infectious Diseases . 2019,第1期

机译：南非患者接受含床蛋白结核治疗的不良药物反应：对自发报道的病例进行评估
3. Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis [J] . Kathryn Schnippel, Cynthia Firnhaber, Francesca Conradie, Applied health economics and health policy . 2018,第1期

机译：依赖于南非利福平抗结核病治疗利福平耐结核的升高成本效果：基于模型的分析
4. Managing the Patient with Adverse Drug Reactions and Liver / Renal Failure [C] . Asian Pacific Society of Respirology . 2003

机译：用不良药物反应和肝脏/肾衰竭管理患者
5. Age appropriate treatment of drug-resistant tuberculosis in South Africa. [D] . Sullivan, Brittney Jayne. 2017

机译：在南非适当年龄治疗耐药结核病。
6. Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases [O] . Jackie Jones, Vanessa Mudaly, Jacqueline Voget, 2019

机译：接受含苯达喹啉治疗的南非患者的药物不良反应：对自发报告病例的评估
7. Cost of managing severe cutaneous adverse drug reactions to first‐line tuberculosis therapy in South Africa [O] . Lauren K. Knight, Rannakoe J. Lehloenya, Edina Sinanovic, 2019

机译：在南非对一线结核病疗法进行严重皮肤不良药物的成本

Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa

摘要

著录项

相似文献

相关主题

期刊订阅